he moment some parents have been anxiously awaiting for months is almost here: The Pfizer-BioNTech Covid-19 vaccine for children aged 5 to 11 will likely be authorized for use in the next week, after completion of a four-step process that begins today.

It is also a moment some portion of parents has been dreading for months. And over the weekend, they made their concerns known to experts on the Food and Drug Administration’s vaccines advisory committee, which meets today to review the evidence on the Pfizer vaccine’s safety and efficacy in kids ages 5 to 11. Members of the the Vaccines and Related Biological Products Advisory Committee (VRBPAC) were deluged by an organized email campaign urging them not to recommend the vaccine.

“Over the weekend I was getting about one email every minute,” said VRBPAC member Paul Offit, a vaccines expert at Children’s Hospital of Philadelphia, who said by the time the weekend was over he had received “hundreds and hundreds.”

Read more…